← All stocks

BioAge Labs, Inc.

BIOA Scheduled selling only

CIK 0001709941 #3181 in the set updated 18 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$7.79M

$4.22M on a plan · $3.57M straight out of an exercise

Sold at will

$0.00

0 of 13 sales

Net

−$7.79M

$0.00 against sales at will

By person

8 insiders · 17 transactions

41.0×

Kristen Fortney holds 41.0 times base salary in stock. $24.61M of shares against $600.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Kristen Fortney last reported holding, valued at $25.19, the price Common Stock was last bought or sold at on the open market here, on 30 Jun 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Fortney Kristen

Chief Executive Officer

—

$4.22M (1) scheduled

−$4.22M

976,949

2.13%

$24.61M

−19.3%

Barton Shane

Principal Accounting Officer

—

$1.58M (2) scheduled

−$1.58M

0.0000%

$0.00

—

RUBIN PAUL D

Chief Medical Officer

—

$1.46M (6) scheduled

−$1.46M

0.0000%

$0.00

—

GOLDSTEIN DOV A MD

Chief Financial Officer

—

$531.83K (4) scheduled

−$531.83K

36,575

0.0797%

$921.21K

+63.2%

ENRIGHT PATRICK G

Director

—

1,710,589

3.73%

$43.08M

—

Cormorant Asset Management, LP entity

Former 10% Owner

—

1,629,529

3.55%

$41.04M

—

Pande Vijay Satyanand

Director

—

1,119,195

2.44%

$28.19M

—

HEALY JAMES

Director

—

26,497

0.0577%

$667.37K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Barton Shane

30 Jun 2026

Principal Accounting Officer

Sold after exercise

20,216

$25.19

$509.18K

Barton Shane

29 Jun 2026

Principal Accounting Officer

Sold after exercise

42,350

$25.21

$1.07M

GOLDSTEIN DOV A MD

23 Apr 2026

Chief Financial Officer

Exercised, kept

3,542

$4.38

$15.51K

RUBIN PAUL D

1 Apr 2026

Chief Medical Officer

Sold after exercise

8,820

$17.81

$157.08K

RUBIN PAUL D

2 Mar 2026

Chief Medical Officer

Sold after exercise

7,433

$20.30

$150.89K

GOLDSTEIN DOV A MD

1 Mar 2026

Chief Financial Officer

Exercised, kept

3,542

$4.38

$15.51K

RUBIN PAUL D

2 Feb 2026

Chief Medical Officer

Sold after exercise

7,433

$18.75

$139.37K

GOLDSTEIN DOV A MD

1 Feb 2026

Chief Financial Officer

Exercised, kept

3,541

$4.38

$15.51K

GOLDSTEIN DOV A MD

16 Jan 2026

Chief Financial Officer

Exercised, kept

3,542

$4.38

$15.51K

Fortney Kristen

13 Jan 2026

Chief Executive Officer

Sold on a plan

233,107

$18.12

$4.22M

GOLDSTEIN DOV A MD

13 Jan 2026

Chief Financial Officer

Sold after exercise

1,923

$21.08

$40.54K

GOLDSTEIN DOV A MD

13 Jan 2026

Chief Financial Officer

Sold after exercise

11,663

$20.54

$239.55K

GOLDSTEIN DOV A MD

13 Jan 2026

Chief Financial Officer

Sold after exercise

4,440

$19.45

$86.37K

GOLDSTEIN DOV A MD

13 Jan 2026

Chief Financial Officer

Sold after exercise

8,974

$18.43

$165.37K

RUBIN PAUL D

2 Jan 2026

Chief Medical Officer

Sold after exercise

7,433

$12.85

$95.49K

RUBIN PAUL D

9 Dec 2025

Chief Medical Officer

Sold after exercise

18,000

$12.00

$216.00K

RUBIN PAUL D

4 Dec 2025

Chief Medical Officer

Sold after exercise

68,897

$10.19

$701.91K

BioAge Labs, Inc.

By person

Individual transactions

What was left out